A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine

被引：0
|
作者：
Kotoe Takayoshi
Kosuke Sagara
Keita Uchino
Hitoshi Kusaba
Naotaka Sakamoto
Atsushi Iguchi
Eishi Baba
机构：
[1] Clinical Research Institute,Department of Medical Oncology
[2] National Hospital Organization Kyushu Medical Center,Department of Medicine and Biosystemic Science
[3] Kyushu University Graduate School of Medical Sciences,Department of Urology
[4] National Hospital Organization Kyushu Medical Center,Department of Comprehensive Clinical Oncology
[5] Faculty of Medical Sciences,undefined
[6] Kyushu University,undefined
来源：
BMC Cancer | / 15卷
关键词：
ABCB1; Adverse event; Bile duct carcinoma; Gemcitabine; Plasma concentration; Renal cell carcinoma; Sunitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib
    Billemont, B.
    Medioni, J.
    Taillade, L.
    Helley, D.
    Meric, J. B.
    Rixe, O.
    Oudard, S.
    BRITISH JOURNAL OF CANCER, 2008, 99 (09) : 1380 - 1382
  • [22] Onset of Male Gynaecomastia in a Patient Treated with Sunitinib for Metastatic Renal Cell Carcinoma
    Pierluigi Ballardini
    Guido Margutti
    Camillo Aliberti
    Roberto Manfredini
    Clinical Drug Investigation, 2009, 29 : 487 - 490
  • [23] Acute acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib
    da Fonseca, Leonardo Gomes
    Barroso-Sousa, Romualdo
    Sabbaga, Jorge
    Hoff, Paulo Marcelo
    CLINICS AND PRACTICE, 2014, 4 (01) : 24 - 26
  • [24] CARDIOTOXICITY IN METASTATIC RENAL CELL CARCINOMA (mRCC) PATIENTS TREATED WITH SUNITINIB (SU)
    Ballatore, Valentina
    Prati, Veronica
    Ruatta, Fiorella
    Galizia, Danilo
    Grignani, Giovanni
    Aglietta, Massimo
    Ortega, Cinzia
    ANTICANCER RESEARCH, 2012, 32 (05) : 1876 - 1877
  • [25] Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib
    Bolzacchini, Elena
    Giordano, Monica
    Bertu, Lorenza
    Bregni, Marco
    Nigro, Olga
    Galli, Luca
    Antonuzzo, Andrea
    Artale, Salvatore
    Barzaghi, Sabrina
    Danova, Marco
    Torchio, Martina
    Pinotti, Graziella
    Dentali, Francesco
    TUMORI JOURNAL, 2022, 108 (05): : 502 - 509
  • [26] Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib - Response
    Rini, Brian I.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12) : 976 - 977
  • [27] Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib
    Fiala, Ondrej
    Ostasov, Pavel
    Rozsypalova, Aneta
    Hora, Milan
    Sorejs, Ondrej
    Sustr, Jan
    Bendova, Barbora
    Travnicek, Ivan
    Filipovsky, Jan
    Finek, Jindrich
    Buchler, Tomas
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4077 - 4086
  • [28] Is There a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
    Keizman, Daniel
    Rouvinov, Keren
    Sella, Avishay
    Gottfried, Maya
    Maimon, Natalie
    Kim, Jenny J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria
    Peer, Avivit
    Carducci, Michael A.
    Mermershtain, Wilmosh
    Leibowitz-amit, Raya
    Weitzen, Rony
    Berger, Raanan
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 281 - 287
  • [29] Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
    Rini, Brian I.
    Cohen, Darrel P.
    Lu, Dongrui R.
    Chen, Isan
    Hariharan, Subramanian
    Gore, Martin E.
    Figlin, Robert A.
    Baum, Michael S.
    Motzer, Robert J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (09): : 763 - 773
  • [30] Onset of Male Gynaecomastia in a Patient Treated with Sunitinib for Metastatic Renal Cell Carcinoma
    Ballardini, Pierluigi
    Margutti, Guido
    Aliberti, Camillo
    Manfredini, Roberto
    CLINICAL DRUG INVESTIGATION, 2009, 29 (07) : 487 - 490
12345